Search

everythinglearnresearchcommunity

for

Search:↓

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

Alopecia areata is linked to reduced T cell function and auto-immunity.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Gut health may influence Alopecia Areata, suggesting new treatments.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Entospletinib effectively prevents eye and skin GVHD in mice.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Alefacept does not effectively treat severe alopecia areata.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Ebastine may help regrow hair in alopecia areata patients.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

SLHA can be hard to diagnose and needs teamwork between specialists.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Thymosin β4 helps improve skin healing and reduce scarring.